activity
20182021
most citedA mathematical modelling framework for the regulation of intra-cellular OCT4 in human pluripotent stem cells

1 citations · 1 across the 3 of their papers we have counts for

collaborators

7 papers

q-bio.SC20211 cited

A mathematical modelling framework for the regulation of intra-cellular OCT4 in human pluripotent stem cells

L E Wadkin, S Orozco-Fuentes, I Neganova +3

Human pluripotent stem cells (hPSCs) have promising clinical applications in regenerative medicine, drug-discovery and personalised medicine due to their potential to differentiate…

q-bio.CB2020

An introduction to the mathematical modelling of iPSCs

Laura E Wadkin, Sirio Orozco-Fuentes, Irina Neganova +3

The aim of this chapter is to convey the importance and usefulness of mathematical modelling as a tool to achieve a deeper understanding of stem cell biology. We introduce key math…

q-bio.CB2020

OCT4 expression in human embryonic stem cells: spatio-temporal dynamics and fate transitions

Laura E Wadkin, Sirio Orozco-Fuentes, Irina Neganova +5

The improved in-vitro regulation of human embryonic stem cell (hESC) pluripotency and differentiation trajectories is required for their promising clinical applications. The tempor…

q-bio.CB2019

The recent advances in the mathematical modelling of human pluripotent stem cells

L E Wadkin, S Orozco-Fuentes, I Neganova +3

Human pluripotent stem cells hold great promise for developments in regenerative medicine and drug design. The mathematical modelling of stem cells and their properties is necessar…

q-bio.QM2019

Quantification of the morphological characteristics of hESC colonies

Sirio Orozco-Fuentes, Irina Neganova, Laura E. Wadkin +5

The maintenance of the pluripotent state in human embryonic stem cells (hESCs) is critical for further application in regenerative medicine, drug testing and studies of fundamental…

q-bio.CB2019

Seeding hESCs to achieve optimal colony clonality

Laura E Wadkin, Sirio Orozco-Fuentes, Irina Neganova +5

Human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) have promising clinical applications which often rely on clonally-homogeneous cell populations. To ach…